There’s a lot going on in the world of biopharma but never fear because we’ve got you covered…

The way the pharma industry has traditionally handled clinical trials does not make participation easy.

We speak with the authors of two studies into extreme increases in US drug pricing, and attempts by lawmakers to bring the price-jackers into line.

What lessons were learned from Operation Warp Speed?

With the threat of COVID-19, vaccine developers needed to enter clinical development and scale-up at unprecedented speed.

We get the lowdown on the Reputation Index, which was recently published by the Association of the British Pharmaceutical Industry.

The pharma industry is one of the biggest targets for cybercrime. How can companies avoid succumbing to attack?

Work at the Max Planck Institute of Molecular Physiology has revealed a welcome surprise: a potential new class of COVID-19 drugs.

DFE Pharma’s Korinde Van Den Heuvel talks to us about what made her company’s new 3D printed tablets possible, and which ills they can cure.

Sitting Down With… Evelina Vågesjö, Chief Executive Officer at Ilya Pharma, Sweden.